FMP
OTC
0.0001 USD
0 (0%)
Mr. Joseph Moscato
Healthcare
Biotechnology
https://www.generex.com/nugenerex-family-of-companies
OTC
NuGenerex Immuno-Oncology, Inc., an oncology company, focuses on the modulation of the immune system to treat cancer. The company is developing immunotherapeutic products and vaccines. It is developing AE37, a peptide immunotherapeutic vaccine, which is in Phase II clinical trials for the treatment of metastatic triple negative breast cancer. The company was formerly known as Antigen Express, Inc. The company was founded in 1993 and is based in Miramar, Florida. NuGenerex Immuno-Oncology, Inc.is a subsidiary of Generex Biotechnology Corporation.
0001804585
US67053X1028
67053X102
10102 USA Today Way
416 364 2551
US
6
Mar 15, 2021
0001804585
OTC
Biotechnology
Healthcare
67053X102
US67053X1028
US
0
142.69
122
10.03k
-
1.0E-5-0.3
0
-
-
-
-
-0
-
https://www.generex.com/nugenerex-family-of-compan...
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.